Total Payments
$1,533
2024 Payments
$633.16
Companies
16
Transactions
65
Medicare Patients
3,166
Medicare Billing
$628,511
Payment Breakdown by Category
Food & Beverage$1,494 (97.4%)
Education$39.70 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,494 | 62 | 97.4% |
| Education | $39.70 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vifor Pharma, Inc. | $272.54 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $225.31 | 8 | $0 (2024) |
| Travere Therapeutics, Inc. | $183.52 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $128.04 | 6 | $0 (2024) |
| Relypsa, Inc. | $124.79 | 1 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $123.45 | 6 | $0 (2024) |
| BAXTER HEALTHCARE | $115.00 | 1 | $0 (2019) |
| Amgen Inc. | $69.30 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $65.27 | 3 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $51.60 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $633.16 | 31 | Travere Therapeutics, Inc. ($139.95) |
| 2023 | $422.04 | 24 | Vifor Pharma, Inc. ($136.83) |
| 2022 | $125.41 | 6 | Vifor Pharma, Inc. ($39.11) |
| 2021 | $99.87 | 1 | AstraZeneca Pharmaceuticals LP ($99.87) |
| 2019 | $252.92 | 3 | Relypsa, Inc. ($124.79) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.25 | General |
| 10/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.53 | General |
| 10/29/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.73 | General |
| Category: NEPHROLOGY | ||||||
| 10/28/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: NEPHROLOGY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Nephrology | ||||||
| 09/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.03 | General |
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 08/06/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Nephrology | ||||||
| 07/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $8.90 | General |
| 07/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEPHROLOGY | ||||||
| 07/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: DIABETES | ||||||
| 07/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Nephrology | ||||||
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.82 | General |
| 05/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.44 | General |
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: DIABETES | ||||||
| 02/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 658 | 1,271 | $319,648 | $123,001 |
| 2022 | 13 | 771 | 1,433 | $371,363 | $151,475 |
| 2021 | 14 | 866 | 1,639 | $424,047 | $183,173 |
| 2020 | 14 | 871 | 1,725 | $374,757 | $170,863 |
Total Patients
3,166
Total Services
6,068
Medicare Billing
$628,511
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 29 | 139 | $80,342 | $37,461 | 46.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 183 | 475 | $66,500 | $27,826 | 41.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 155 | $31,000 | $13,955 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 203 | $52,780 | $12,954 | 24.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 13 | 26 | $12,012 | $5,369 | 44.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 41 | $13,325 | $5,284 | 39.7% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 27 | 27 | $18,927 | $4,946 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $9,225 | $3,940 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 34 | $10,200 | $3,287 | 32.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 14 | $5,950 | $2,272 | 38.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 27 | 41 | $7,831 | $2,164 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,780 | $1,672 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 26 | $4,784 | $1,629 | 34.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 20 | $740.00 | $194.20 | 26.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 12 | 12 | $252.00 | $47.28 | 18.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 42 | 214 | $123,692 | $57,569 | 46.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 229 | 509 | $71,260 | $27,576 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 197 | $51,220 | $16,382 | 32.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 104 | 183 | $36,600 | $14,282 | 39.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 58 | $18,850 | $8,663 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 52 | $15,600 | $7,004 | 44.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 48 | 51 | $11,475 | $5,152 | 44.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 17 | $7,854 | $3,893 | 49.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 40 | 62 | $11,842 | $3,423 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $10,200 | $3,260 | 32.0% |
About Dr. Janice Nigos, M.D
Dr. Janice Nigos, M.D is a Nephrology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609106962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janice Nigos, M.D has received a total of $1,533 in payments from pharmaceutical and medical device companies, with $633.16 received in 2024. These payments were reported across 65 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,494).
As a Medicare-enrolled provider, Nigos has provided services to 3,166 Medicare beneficiaries, totaling 6,068 services with total Medicare billing of $628,511. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Cincinnati, OH
- Active Since 01/10/2010
- Last Updated 07/25/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1609106962
Products in Payments
- Veltassa (Drug) $397.33
- JARDIANCE (Drug) $128.04
- FARXIGA (Drug) $125.44
- TARPEYO (Drug) $123.45
- Renal - PD (Device) $115.00
- JYNARQUE (Drug) $65.27
- KRYSTEXXA (Biological) $41.25
- RAYALDEE (Drug) $38.47
- BENLYSTA (Biological) $24.75
- Sylvant (Drug) $24.28
- CARBAGLU (Drug) $24.27
- CYSTADROPS (Drug) $23.96
- TAVNEOS (Drug) $23.30
- IBSRELA (Drug) $21.39
- Aranesp (Biological) $21.29
- JESDUVROQ (Drug) $16.33
- Rayaldee (Drug) $13.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Cincinnati
Francisco Flores, M.d, M.D
Nephrology — Payments: $163,331
Nephrology $163,331
Dr. Tahir Sajjad, M.d, M.D
Nephrology — Payments: $37,686
Nephrology $37,686
Dr. Arshdeep Tindni, M.d, M.D
Nephrology — Payments: $31,882
Nephrology $31,882
Dr. Joseph Kremer, M.d, M.D
Nephrology — Payments: $29,341
Nephrology $29,341
Dr. Karl Pembaur, M.d, M.D
Nephrology — Payments: $7,169
Nephrology $7,169
Dr. Ajay Srivastava, Md, MD
Nephrology — Payments: $6,069
Nephrology $6,069